Legal Opinion
Aetna, Inc. v. Pfizer, Inc.
Court of Appeals for the First Circuit
Decided April 3, 2013No. 11-1595PublishedCited by 13 opinions
1Opinion of the Court
LYNCH, Chief Judge.
In Kaiser Foundation Health Plan, Inc. v. Pfizer, Inc. (Kaiser), 712 F.3d 21, Nos. 11-1904, 11-2096, 2013 WL 1320408 (1st Cir.2013), a related appeal in which we also issue an opinion today, we affirmed a court and jury verdict against Pfizer, Inc. (“Pfizer”), under section 1962 of the Racketeer Influenced and Corrupt Organizations Act (RICO), 18 U.S.C. §§ 1961-68, and a state statute, for fraudulent marketing of off-label uses of its drug Neurontin. The arguments presented in Kaiser and in an other related appeal in which we issue an opinion today, Harden Manufacturing Co.…
2Cases cited10 opinions
- Holmes v. Securities Investor Protection CorporationSupreme Court of the United States · 1992
- Bridge v. Phoenix Bond & Indemnity Co.Supreme Court of the United States · 2008
- Sutliffe v. Epping School DistrictCourt of Appeals for the First Circuit · 2009
- Sullivan v. City of SpringfieldCourt of Appeals for the First Circuit · 2009
- Lewis v. City Of BostonCourt of Appeals for the First Circuit · 2003
5 more not listed; retrieve them via the Exa API.
3Cited by13 opinions
- CGC Holding Co. v. Broad & CasselCourt of Appeals for the Tenth Circuit · 2014
- United States Ex Rel. Booker v. Pfizer, Inc.Court of Appeals for the First Circuit · 2017
- Painters & Allied Trades Dist. Council 82 Health Care Fund v. Forest Pharm., Inc. (In Re Celexa & Lexapro Mktg. & Sales Practices Litig.)Court of Appeals for the First Circuit · 2019
- Harden Manufacturing Corp. v. Pfizer, Inc.Court of Appeals for the First Circuit · 2013
- Travelers Indemnity Co. v. Cephalon, Inc.District Court, E.D. Pennsylvania · 2014
8 more not listed; retrieve them via the Exa API.